JACC. Case reports · 2026
Early Prosthetic Thrombosis After Transcatheter Tricuspid Valve Replacement: A Word of Caution.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Trinca Francesco, Bousmaha Nassim, Porterie Jean, Mohammadi Siamak, Dumont Eric, M-Labbé Benoît, O'Connor Kim, Poulin Anthony, Rodès-Cabau Josep, Kalavrouziotis Dimitri
Аннотация
BACKGROUND: Determinants of early prosthetic thrombosis following transcatheter tricuspid valve replacement (TTVR) are unknown.
CASE SUMMARY: A 70-year-old man with severe tricuspid regurgitation underwent an uneventful TTVR using the EVOQUE system (Edwards Lifesciences). Intravenous heparin was temporarily suspended a few days after the procedure to insert a permanent pacemaker. Sudden clinical deterioration occurred in the following days. Echocardiography demonstrated extensive thrombosis of the TTVR prosthesis, requiring surgical removal. Tricuspid valve repair was not possible because of the anchoring mechanism of the prosthesis, and a tricuspid valve replacement was necessary. The patient's postoperative course was unremarkable.
DISCUSSION: The optimal management of anticoagulation in patients undergoing TTVR needs to be elucidated.
TAKE-HOME MESSAGES: Early interruption of anticoagulation after TTVR may be associated with severe prosthetic thrombosis in selected high-risk patients. Surgical TTVR explantation may damage the native tricuspid leaflets and subvalvular apparatus, reducing the likelihood of valve repair.
CASE SUMMARY: A 70-year-old man with severe tricuspid regurgitation underwent an uneventful TTVR using the EVOQUE system (Edwards Lifesciences). Intravenous heparin was temporarily suspended a few days after the procedure to insert a permanent pacemaker. Sudden clinical deterioration occurred in the following days. Echocardiography demonstrated extensive thrombosis of the TTVR prosthesis, requiring surgical removal. Tricuspid valve repair was not possible because of the anchoring mechanism of the prosthesis, and a tricuspid valve replacement was necessary. The patient's postoperative course was unremarkable.
DISCUSSION: The optimal management of anticoagulation in patients undergoing TTVR needs to be elucidated.
TAKE-HOME MESSAGES: Early interruption of anticoagulation after TTVR may be associated with severe prosthetic thrombosis in selected high-risk patients. Surgical TTVR explantation may damage the native tricuspid leaflets and subvalvular apparatus, reducing the likelihood of valve repair.